Clinical Trial Update: NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a multiple ascending dose study (Phase 1/Phase 2) of NOX-E36 in healthy volunteers and patients with Type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NOX-E36

Snippet

Sponsor: TME Pharma AG | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED